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Abstract
Computer aided diagnosis (CAD) software is not yet widely used in clinic. This paper aims to identify possible reasons why.
Firstly, the technical maturity of CAD is explored through analysis of diagnostic accuracy metrics in one example application,
the automated classiﬁcation of Ioﬂupane I123 (DaTSCAN) images. Software is developed for image classiﬁcation based on well-
established eigenimage techniques. Using a publicly available database of images an area under the Receiver Operator Curve
(AUROC) of 0.980 is achieved.
Given these impressive results the main blockage to clinical adoption, both in DaTSCAN classiﬁcation and potentially in other
applications, is likely to relate to wider issues. These are explored with reference to the demands of the National Institute for
Health and Care Excellence (NICE) evaluation processes. It is postulated that in order to enable wider adoption a greater focus on
proving the safety, eﬃcacy and cost eﬀectiveness of CAD may be required.
c© 2016 The Authors. Published by Elsevier B.V.
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1. Introduction
The interpretation of medical images relies largely on the ability of a human observer to visually identify charac-
teristics of an image that are associated with pathological changes. This is not always a straightforward process and
is inherently subjective. In extreme cases clinically signiﬁcant errors may be made (the incidence of such errors is
estimated to be 1-20%1,2).
Recently, the role of the radiologist has become even harder. With the progression of imaging hardware and
technology, the number and complexity of images produced by modern scanners is rapidly increasing3. The volume
of information generated from individual scans continues to grow and as a practising Clinical Scientist it is clear that
interpretation by humans using standard techniques is becoming more demanding (a problem often referred to as data
overload4). It is envisaged that new ways of working will be required in order to cope5.
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Given these trends it is argued that Computer Aided Diagnosis (CADx) and Computer Aided Detection (CADe)
software, henceforth referred to together as CAD, will eventually become a necessity in radiology departments. How-
ever, despite the obvious and growing need for computer assistance CAD software is not yet widely used in the clinic
outside of mammography in the USA6, and the number of commercial CAD systems is very limited5.
This paper attempts to clarify why clinical uptake has been so modest. The ﬁrst step in this analysis is an exploration
of the technical maturity of CAD algorithms. If it can be shown that CAD technology is equal to the task of automated
diagnosis then it must be assumed that the blockage to clinical translation lies elsewhere. By way of example, the
current suitability of CAD for the automated classiﬁcation of Ioﬂupane I-123 (DaTSCAN) images is examined.
A well-established CAD technology, eigenimage analysis, is demonstrated and applied to a DaTSCAN image
database. Performance ﬁgures usefully quantify diagnostic accuracy and are compared with methods reported in the
literature. Beyond this, other aspects of clinical uptake of CAD are considered, with speciﬁc reference to the National
Institute for Health and Care Excellence (NICE) evaluation processes. Positive recommendations from NICE can be
highly inﬂuential in persuading hospitals to adopt certain technologies. It is prudent to be aware of such requirements,
and their impact in the context of low clinical adoption of CAD.
The novelty of this paper is not in the methods applied to generate CAD output, but the realisation that adoption of
CAD in the ﬁeld requires more than a novel algorithm; acceptance of the technology implies acceptance by the end
user, which relies heavily on a structured pathway to adoption
1.1. Eigenimage analysis
Fundamentally, this widely used model involves the application of principal component analysis (PCA) to a set of
training images, where the pixel values are the feature of interest. The principal components or eigenimages output
from PCA are then used for subsequent processing of test images, in particular for classiﬁcation purposes. One
common method for performing PCA is through eigen-decomposition of the variance-covariance matrix:
XXT = EDET (1)
Where X is a matrix containing the pixel values of test images, concatenated into vectors, E is an orthonormal ma-
trix containing the eigenvectors of XXT (i.e. the eigenimages) and D is a diagonal matrix containing the eigenvalues.
The eigenimages are usually stated in order of reducing variance such that the ﬁrst eigenimage describes the largest
amount of variance in the data.
Eigenimages can be used as a basis for classiﬁcation in a number of ways. In face recognition tasks, where
eigenimage analysis has been most extensively exploited, the distance between test images and training images in
multidimensional eigenimage space is used as the discrimination metric7. In medical imaging, similar approaches
can be used to establish whether test images are part of normal or pathological groups, usually based on a small subset
of the generated eigenimages. In the following section the Mahalanobis distance from a group of normal training data
in eigenimage space is used as the discrimination method.
2. Method
DaTSCAN is a radioactive tracer with a high aﬃnity for dopamine active transporter (DaT), a protein which
resides in the membrane of presynaptic axon terminals in the striatum. It is administered prior to gamma camera
SPECT imaging, for diagnosis of Parkinsonian syndromes such as Parkinsons Disease (PD). The PPMI database
includes a collection of reconstructed DaTSCAN images taken from controls and diagnosed PD patients (www.ppmi-
info.org/data). This has been used extensively by CAD specialists for validating a range of diﬀerent algorithms8,9,10.
Striatal uptake of DaTSCAN reduces in extent and intensity with increasing severity of disease, creating two distinct
voxel intensity patterns in the normal and pathological populations: a comma appearance for normal images and a dot
appearance for PD patients.
The performance of eigenimage analysis in relation to DaTSCAN imaging was assessed by measuring the area
under the receiver operator curve (AUROC), which provides the most comprehensive description of diagnostic ac-
curacy11. Although of reduced clinical relevance, for comparison purposes the maximum accuracy of the algorithm
on the ROC curve was also reported. Processing was carried out as follows. All steps were performed using Matlab
software:
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Figure 1. Example DaTSCAN images. Four reconstructed slices are shown from within the 3D brain image.
Figure 2. ROC curve derived from Mahalanobis distance measurements. The blue circle is the point of maximum diagnostic accuracy
1. Images in the PPMI database were aﬃne registered to a template (chosen from the controls) so as to remove the
eﬀects of diﬀerences in patient positioning. Registration was carried out using the Sheﬃeld Image Registration
Toolkit (ShIRT12). A striatal region of interest (ROI) was manually drawn on the template image.
2. The ROI was used to mask intensity values outside of the striata in all control and PD images, thereby reducing
the inﬂuence of diagnostically unimportant tissues. Data were intensity normalised to the mean intensity level in
the striatal region to account for diﬀerences in scaling.
3. 100 eigenimages were generated from the ﬁrst 100 controls (training images), after mean centring. The coeﬃ-
cients of these datasets in eigenimage space were retained
4. 100 control and 100 PD test images, separate to the training data, were projected on to the ﬁrst 5 eigenimages. The
Mahalanobis distances of each test image from the training images in the eigenimage subspace was measured.
5. An ROC curve was generated from the Mahalanobis distance measurements
3. Results
The ROC curve is displayed in ﬁgure 2. AUROC was 0.980 (95% conﬁdence interval 0.961-1.000). The maximum
accuracy achieved was 94.0%, highlighted on the ROC curve by the blue circle in ﬁgure 2. These results are presented
in table 1, alongside results reported by other authors using the same PPMI image database.
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Table 1. Performance results from automated diagnosis of images in the PPMI database
Authors Method Num. of images Accuracy
(max)
AUROC
J. Taylor, J. Fenner Eigenimage analysis of pixels. Maha-
lanobis distance as discrimination met-
ric.
200 controls, 100
PD
94.0% 0.980
F.J. Martinez-Murcia,
J.M. Gorriz, J. Ramirez,
I.A. Illan, A. Ortiz9
Independent component analysis of ex-
tracted features, input to Support Vec-
tor Machine for discrimination
114 controls, 175
PD
91.3%
F.J. Martinez-Murcia,
J.M. Gorriz, J. Ramrez,
I.A. Illan, C.G. Pun-
tonet8
Extracted features input to Support
Vector Machine for discrimination
209 controls, 445
PD
97.9%
R. Prashanth, S.D. Roy,
P.K. Mandal, S. Ghosh10
Extracted features input to Support
Vector Machine for discrimination
181 controls, 369
PD
96.1%
4. Discussion
The results obtained from this exercise show that an accurate CAD algorithm for DaTSCAN can be created with a
relatively simple algorithm based on eigenimages. Established methods were deliberately chosen for this study since
they are better understood and represent a lower risk for clinical adoption. Validation was carried out using a high-
quality, multi-centre, prospective patient database, providing strong evidence that eigenimage analysis could be an
eﬀective tool for the clinic. The strength of CAD for automated diagnosis in DaTSCAN imaging is further enhanced
by results from other authors (see table 1), who have achieved accuracies of up to 98%.
Although conducted with diﬀerent data, a previous test of the classiﬁcation performance of human observers re-
ported an accuracy of 91% for DaTSCAN imaging13. The evidence from table 1 suggests that all CAD methods,
covering diﬀerent levels of complexity, exceed this performance. Therefore, algorithm sophistication is not a barrier
to adoption in this case.
The results strongly suggest that CAD is likely to be suﬃciently eﬀective in this application to be suitable for
clinical translation. However, outside of software tools which simply quantify and display ratios of counts in diﬀerent
image regions (e.g. Hermes BRASS, GE DaTQUANT), CAD is not yet used routinely by radiologists in DaTSCAN
imaging. This is despite recent audit data showing a disagreement between radiologists in test centres and a panel of
experts in 8% of cases14.
The relative mismatch between high accuracy ﬁgures in the literature, from a range of algorithms, and low clinical
CAD uptake suggests that other factors must have a signiﬁcant impact on the route to translation. In this paper a
structured approach to understanding the wider issues around translation is proposed.
The consumers of CAD are mostly radiologists and clinical radiology departments. In the UK these consumers
are likely to be signiﬁcantly inﬂuenced by NICE guidelines. Therefore, analysis and understanding of what NICE
evaluation requires may lead to further insights into the barriers to clinical adoption.
4.1. NICE evaluation processes
One of the key roles of NICE is to produce guidance for health and social care professionals in the UK and
further aﬁeld. New diagnostic technologies, such as CAD, can be alerted to NICE through the Technology Evaluation
Programme or the Diagnostic Assessment Programme. Both programmes are closely related, the major diﬀerence
being that the Technology Evaluation Programme is focused on technologies that achieve a similar clinical beneﬁt at
reduced cost to the health system or more beneﬁt at the same cost as current practice. The Diagnostic Assessment
97 Jonathan Taylor and John Fenner /  Procedia Computer Science  90 ( 2016 )  93 – 98 
Table 2. Summary of the main requirements for NICE evaluation (and approval) along with an assessment of the implications for CAD software
development
Requirements for NICE evaluation Implications for CAD software
Regulation
Technology must be licensed for the intended
purpose. It is likely that software will need to be CE
marked (in Europe) in line with the requirements of
the Medical Devices Directive (MDD). This is likely
to require adherence to appropriate standards and
auditing by an external notiﬁed body.
Software must be created according to an appropri-
ate quality management system. For risk assessment
and validation purposes a detailed understanding of
how CAD components perform in diﬀerent scenarios
is likely to be required.
Depending on the device classiﬁcation, clinical investi-
gations are likely to be required to prove that the tech-
nology is safe and eﬀective. This will require testing in
realistic clinical environments
Clinical impact
The evidence base detailing the clinical impact of the
technology must be available to enable an informed
decision about adoption. In particular a performance
comparison of the new technology as compared to stan-
dard of care is required. NICE places emphasis on high
quality research where bias is minimised. The evidence
must be of suﬃcient quantity and consistency to enable
a robust recommendation.
Proof of the diagnostic eﬀectiveness of CAD, as com-
pared to standard care (i.e. visual analysis by radiol-
ogists), must be collated. Ideally, test results should
reference accurate gold-standard diagnoses and tests
should ideally be performed in realistic clinical scenar-
ios with randomly selected data. Small test datasets are
unlikely to be suitable.
Health economics
Evidence base of economic data in relation to the tech-
nology must be available. For the Technology Assess-
ment Programme economic analysis can be presented
using a cost-consequence methodology. Overall costs
to the NHS must be equal to or less than those of cur-
rent standard care. For the Diagnostic Assessment Pro-
gramme more in-depth economic analysis is required,
including cost eﬀectiveness analysis. NICE does not
use speciﬁc thresholds but above £30,000 per Quality
Adjusted Life Year (QALY) gained a strong case for
support is required.
The impact of CAD in terms of direct costs and indirect
costs must be prepared. This may require economic
modelling. If costs can be shown to be less or equal to
those of standard care then NICEs decision will largely
fall on clinical evidence.
If overall costs are greater than that of standard care it
may be useful to perform cost eﬀectiveness analysis,
generating evidence through the care pathway, to esti-
mate the likely cost per QALY gained (and ensure it
is less than £30,000). If cost eﬀectiveness ﬁgures are
uncertain then NICEs decision will again fall on the
clinical evidence
Programme, on the other hand, is focused on the introduction of technology that is likely to result in an overall increase
in costs to the NHS. Table 2 shows a list of the common requirements of the two NICE evaluation programmes, based
on published guidance15,16, along with an assessment of the implications for the development of approved clinical
CAD software. Table 2 illustrates that there are a number of signiﬁcant hurdles that must be navigated before NICE
approval is granted. Although this is not a pre-requirement for adoption within a local centre, without it wider adoption
is challenging, whilst the presence of approval is likely to dramatically improve uptake both in the UK and elsewhere.
Only a very small fraction of current CAD algorithms are likely to be able to meet requirements related to regula-
tory adherence and clinical and economic evidence. NICE approval is only granted if the research base demonstrates
that impact in terms of improved care or reduced costs is substantial. Given previous criticisms of CAD research,
particularly with regards to the relevance and signiﬁcance of reported results5,3,17,18, and the general lack of economic
analysis, NICE approval is likely to be unrealistic for most CAD applications, including automated DaTSCAN anal-
ysis. Therefore, a greater research eﬀort directed towards proving the safety, eﬃcacy and cost eﬀectiveness of CAD
may be required.
Unfortunately, overcoming regulatory hurdles and testing in clinic against the current standard of care (i.e. against
unaided radiologists) are likely to be expensive processes. This latter point indicates that one of the biggest blocks on
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clinical adoption of CAD may be related to ﬁnances, particularly if, as is often the case, CAD development is driven
by commercial organisations.
5. Conclusion
This study has shown that a relatively simple, well-established technology, eigenimage analysis, can perform well
when applied to the automated classiﬁcation of DaTSCAN images. Accuracy ﬁgures were in line with results achieved
through more complex, highly optimised algorithms applied to the same database of images. Due to the simplicity
of DaTSCAN image appearances this task is one of the more straightforward problems in CAD research. However,
results do suggest that in at least some applications CAD technologies are ripe for clinical adoption.
As with radiological applications in general, the routine use of CAD for DaTSCAN analysis is very limited. It is
in this context that the requirements of NICE evaluation processes provide an insight as to which other factors may be
a barrier to clinical translation.
The NICE evaluation processes most relevant to CAD software require adherence to medical device regulations,
the generation of evidence comparing CAD with standard of care and economic evidence showing the impact on
healthcare systems costs. In most cases CAD algorithms fall short in all these categories. Therefore, although NICE
approval is an ambitious target, results do suggest that more research eﬀort should be expended in generating evidence
that is of concern to intended consumers, rather than continually adapting and reﬁning CAD technology.
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